These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17613445)

  • 21. Generic medicines: Greek physicians' perceptions and prescribing practices.
    Tsiantou V; Zavras D; Kousoulakou H; Geitona M; Kyriopoulos J
    J Clin Pharm Ther; 2009 Oct; 34(5):547-54. PubMed ID: 19744010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
    Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tense prescriptions? Alzheimer medications and the anthropology of uncertainty.
    Leibing A
    Transcult Psychiatry; 2009 Mar; 46(1):180-206. PubMed ID: 19293285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using stated preference and revealed preference modeling to evaluate prescribing decisions.
    Mark TL; Swait J
    Health Econ; 2004 Jun; 13(6):563-73. PubMed ID: 15185386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing treatment effects in a clinical sample of patients with probable Alzheimer's disease treated with two different cholinesterase inhibitors.
    Caffarra P; Vezzadini G; Copelli S; Dieci F; Messa G; Nonis E; Venneri A
    Acta Biomed; 2007; 78(1):16-21. PubMed ID: 17687812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 27. Family physicians' perceptions and predictors regarding the competence of a person with Alzheimer's disease.
    Werner P
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):320-6. PubMed ID: 17066429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
    Chankrachang S; Senanarong V; Poungvarin N; Phanthumchinda K; Tavichachart N; Praditsuwan R; Nidhinandana S
    J Med Assoc Thai; 2008 Sep; 91(9):1343-9. PubMed ID: 18843862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term rivastigmine treatment in a routine clinical setting.
    Minthon L; Wallin AK; Eriksson S; Wattmo C; Andreasen N
    Acta Neurol Scand; 2009 Mar; 119(3):180-5. PubMed ID: 18759798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?
    Carnahan RM; Lund BC; Perry PJ; Chrischilles EA
    J Am Geriatr Soc; 2004 Dec; 52(12):2082-7. PubMed ID: 15571547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.
    Rosenblatt A; Samus QM; Onyike CU; Baker AS; McNabney M; Mayer LS; Brandt J; Lyketsos CG
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):178-84. PubMed ID: 17676652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical inquiries. Do patients at high risk of Alzheimer's disease benefit from early treatment?
    Holt J; Stiltner L; Wallace R; Raetz J
    J Fam Pract; 2009 Jun; 58(6):320-2. PubMed ID: 19508846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's disease and their carers.
    Smith B; Chur-Hansen A; Neale A; Symon J
    Australas Psychiatry; 2008 Dec; 16(6):433-7. PubMed ID: 18777227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Did knowledge, opinions, background, and health authority advice influence early prescribing of the novel Alzheimer's disease drug donepezil in general practice?--national postal survey.
    Martin RM; Rink E; Wilkinson DG; Mann RD
    Pharmacoepidemiol Drug Saf; 1999 Oct; 8(6):413-22. PubMed ID: 15073903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey.
    McCarberg BH; Nicholson BD; Todd KH; Palmer T; Penles L
    Am J Ther; 2008; 15(4):312-20. PubMed ID: 18645331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donepezil in the treatment of patients with Alzheimer's disease.
    Tsuno N
    Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.